Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now early-phase tilt small index

Hemiparesis After Stroke: early-phase trial registry

3 of 3 indexed Hemiparesis After Stroke trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #5,209 of 28,707 conditions by registered trial count.

3 US clinical trials · 3 currently recruiting · #5,209 of 28,707 conditions by registered trial count

Hemiparesis After Stroke: 3 US clinical trials tracked, 3 recruiting.

Hemiparesis After Stroke is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Marco Capogrosso, running 1 of these trials.

Enrollment posture brief

Registry condition hemiparesis-after-stroke

OPEN 3 | RECR 100% | LATE 0 | EARLY 1 | RANK #5209 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Hemiparesis After Stroke (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Hemiparesis After Stroke

Hemiparesis After Stroke lists 3 open slots (100% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Hemiparesis After Stroke on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Hemiparesis After Stroke is recruiting above its size-band peers.

    3 of 3 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 11

Phase Distribution

PhaseTrial count
Phase 1 1

Top Sponsors

Named interventions

Most-linked intervention names on Hemiparesis After Stroke records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Psilocybin (Usona Institute) Drug
1 trials
Spinal Cord Stimulator (Medtronic Inceptiv™ System) Device
1 trials
SOC Other
1 trials
Robotic Exoskeleton Device
1 trials
Physical Therapy Other
1 trials

US sites by state

Facility locations filed on Hemiparesis After Stroke trials. A trial with sites in several states counts in each.

Pennsylvania 1 trials
New Jersey 1 trials
Maryland 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Hemiparesis After Stroke page

3 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 3 Hemiparesis After Stroke trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Marco Capogrosso sponsors the most Hemiparesis After Stroke trials on record, review their full trial history before evaluating a specific study. See Marco Capogrosso's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Hemiparesis After Stroke condition card totals 3 registered trials; most-linked intervention Psilocybin (Usona Institute); top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.